Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] (Toxicology Reports (2024) 13, (S2214750024001483), (10.1016/j.toxrep.2024.101765))

Hossein Majidzadeh, Mostafa Araj-Khodaei, Ayuob Aghanejad, Maryam Ghaffari, Amir Jafari, Forough Jenanifard, Jafar Ezzati Nazhad Dolatabadi, Hashem Andishmand, Michael R. Hamblin

Research output: Contribution to journalComment/debate

Abstract

The authors regret <We would like to honestly inform that due to the inadvertent mistake of one of authors in adjusting and aligning the electron microscope images of the nanosystem components in Fig. 3, we recently realized that Fig. 3 is not presented correctly and therefore, the corrected figure of the MTX-PAMAM-BER co-delivery system is given below. Also, we forget to mention that Fig. 6B republished with permission from reference number 3, which is a figure of untreated HeLa cells. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number101957
JournalToxicology Reports
Volume14
DOIs
Publication statusPublished - Jun 2025

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] (Toxicology Reports (2024) 13, (S2214750024001483), (10.1016/j.toxrep.2024.101765))'. Together they form a unique fingerprint.

Cite this